Incyte (INCY) Income towards Parent Company (2010 - 2026)

Incyte (INCY) posted Income towards Parent Company of $303.3 million for Q1 2026, up 1.35% on a QoQ basis from $299.3 million in Q4 2025, and up 91.73% year-over-year from $158.2 million in Q1 2025.

Incyte (INCY) Income towards Parent Company (2010 - 2026) Analysis & Trends

Incyte's Income towards Parent Company history runs 17 years deep, the most recent figure standing at $303.3 million for Q1 2026.

  • Quarterly Income towards Parent Company rose 91.73% year-over-year to $303.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 6631.44% YoY) and the FY2025 annual result came in at $1.3 billion, up 3844.96% from the prior year.
  • Income towards Parent Company was $303.3 million for Q1 2026 at Incyte, up from $299.3 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $424.2 million in Q3 2025 and bottomed at -$444.6 million in Q2 2024.
  • A 5-year average of $150.6 million and a median of $169.5 million in 2024 frame the typical range for Income towards Parent Company.
  • Peak annual rise in Income towards Parent Company reached 681.22% in 2024, while the deepest fall reached 318.43% in 2024.
  • Incyte's Income towards Parent Company stood at $28.5 million in 2022, then soared by 606.51% to $201.1 million in 2023, then increased by 0.07% to $201.2 million in 2024, then jumped by 48.74% to $299.3 million in 2025, then rose by 1.35% to $303.3 million in 2026.
  • Business Quant data shows INCY's Income towards Parent Company at $303.3 million in Q1 2026, $299.3 million in Q4 2025, and $424.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 303.33 Mn
Dec 31, 2025 299.28 Mn
Sep 30, 2025 424.17 Mn
Jun 30, 2025 405.00 Mn
Mar 31, 2025 158.20 Mn
Dec 31, 2024 201.21 Mn
Sep 30, 2024 106.46 Mn
Jun 30, 2024 -444.60 Mn
Mar 31, 2024 169.55 Mn
Dec 31, 2023 201.08 Mn
Sep 30, 2023 171.27 Mn
Jun 30, 2023 203.55 Mn
Mar 31, 2023 21.70 Mn
Dec 31, 2022 28.46 Mn
Sep 30, 2022 112.78 Mn
Jun 30, 2022 161.43 Mn
Mar 31, 2022 37.99 Mn
Dec 31, 2021 563.86 Mn
Sep 30, 2021 181.74 Mn
Jun 30, 2021 149.46 Mn